0001645113-23-000009.txt : 20230109
0001645113-23-000009.hdr.sgml : 20230109
20230109182159
ACCESSION NUMBER: 0001645113-23-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230105
FILED AS OF DATE: 20230109
DATE AS OF CHANGE: 20230109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leonard Frank X
CENTRAL INDEX KEY: 0001822879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 23519235
MAIL ADDRESS:
STREET 1: 20 VALLEY STREAM PARKWAY,
STREET 2: SUITE 300
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
wf-form4_167330650457668.xml
FORM 4
X0306
4
2023-01-05
0
0001645113
NovoCure Ltd
NVCR
0001822879
Leonard Frank X
C/O NOVOCURE INC.,
1550 LIBERTY RIDGE DRIVE, SUITE 115
WAYNE
PA
19087
0
1
0
0
President, CNS Cancers US
Ordinary Shares
2023-01-05
4
S
0
2345
119.0077
D
48111
D
Ordinary Shares
2023-01-05
4
S
0
417
108
D
47694
D
Ordinary Shares
2023-01-05
4
S
0
526
115.0348
D
47168
D
Ordinary Shares
2023-01-05
4
S
0
1010
117
D
46158
D
Ordinary Shares
2023-01-05
4
M
0
7826
14.37
A
53984
D
Ordinary Shares
2023-01-05
4
S
0
7826
108
D
46158
D
Ordinary Shares
2023-01-05
4
M
0
7500
11.46
A
53658
D
Ordinary Shares
2023-01-05
4
S
0
7500
108
D
46158
D
Ordinary Shares
2023-01-05
4
M
0
5517
7.15
A
51675
D
Ordinary Shares
2023-01-05
4
S
0
5517
108
D
46158
D
Ordinary Shares
2023-01-05
4
M
0
7183
21.15
A
53341
D
Ordinary Shares
2023-01-05
4
S
0
7183
114.0001
D
46158
D
Ordinary Shares
2023-01-05
4
M
0
7183
21.15
A
53341
D
Ordinary Shares
2023-01-05
4
S
0
7183
120
D
46158
D
Options to Buy Ordinary Shares
14.37
2023-01-05
4
M
0
7826
0
D
2025-02-23
Ordinary Shares
7826.0
0
D
Options to Buy Ordinary Shares
11.46
2023-01-05
4
M
0
7500
0
D
2026-02-24
Ordinary Shares
7500.0
0
D
Options to Buy Ordinary Shares
7.15
2023-01-05
4
M
0
5517
0
D
2027-02-21
Ordinary Shares
5517.0
0
D
Options to Buy Ordinary Shares
21.15
2023-01-05
4
M
0
7183
0
D
2028-02-26
Ordinary Shares
7183.0
10479
D
Options to Buy Ordinary Shares
21.15
2023-01-05
4
M
0
7183
0
D
2028-02-26
Ordinary Shares
7183.0
17662
D
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 2,345 shares in multiple trades at prices ranging from $119.00 to $119.07. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Leonard.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 526 shares in multiple trades at prices ranging from $115.00 to $115.59. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 5, 2023, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leonard, Mr. Leonard sold 7,183 shares in multiple trades at prices ranging from $114.00 to $114.03. The price reported above reflects the weighted average sale price. Mr. Leonard hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested as of the date hereof.
By: /s/ Steven Robbins, Attorney in Fact for Frank X. Leonard
2023-01-09